Multimodal Anesthesia-Analgesia for Patients with Huntington's Disease: A Case Series

Georgios Papastratigakis1, Maria Christofaki2, Alexandra Papaioannou3

  • 1Department of Anesthesiology, University Hospital of Heraklion, Heraklion, Crete, Greece. papastratigakisg@gmail.com.

Acta Medica Academica
|February 12, 2025
PubMed

Insights

Modern anesthetic strategies effectively manage Huntington's disease (HD) patients undergoing surgery. Opioid-sparing multimodal approaches ensure safe anesthesia, even when locoregional techniques are not feasible, leading to uncomplicated recoveries.

Area of Science:

  • Anesthesiology
  • Neurology
  • Genetics

Background:

  • Huntington's disease (HD) presents unique anesthetic challenges due to its progressive neurodegenerative nature.
  • Managing patients with HD requires careful consideration of anesthetic techniques to mitigate risks associated with the disease and its symptoms, such as chorea.

Purpose of the Study:

  • To demonstrate the successful anesthetic management of patients with Huntington's disease (HD) undergoing major surgery.
  • To highlight the efficacy of modern, opioid-sparing, multimodal anesthetic strategies in this patient population.

Main Methods:

  • Presentation of two case studies involving patients with Huntington's disease receiving general anesthesia for major surgical procedures.
  • Utilized opioid-sparing, multimodal anesthetic-analgesic strategies, including dexmedetomidine infusion, when locoregional techniques were not feasible due to patient factors (chorea) or resource limitations.
  • Managed patients with concurrent alcohol use disorder (AUD) and HD.

Main Results:

  • Both patients with Huntington's disease experienced successful anesthetic management and uncomplicated postoperative courses.
  • A brief amelioration of choreic movements was observed postoperatively in both patients following the anesthetic intervention.
  • This study reports the first case of a patient with Huntington's disease and concurrent AUD undergoing general anesthesia with these modern strategies.

Conclusions:

  • Modern, opioid-sparing, multimodal anesthetic strategies are safe and effective for managing patients with Huntington's disease undergoing major surgery.
  • These approaches provide a viable alternative to locoregional techniques, ensuring patient safety and minimizing opioid-related adverse effects.
  • Dexmedetomidine may offer benefits in managing chorea symptoms perioperatively in HD patients.
Abstract

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
189
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
429
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
210
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
571
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
187
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
349